25I-NBF
25I-NBF
25I-NBF is a synthetic compound that belongs to the class of phenethylamines. It is a derivative of the 2C family of psychedelic phenethylamines and is closely related to 25I-NBOMe, a more well-known compound in the same series. 25I-NBF is known for its potent serotonin receptor agonist activity, particularly at the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects.
Chemical Structure and Properties
25I-NBF is chemically known as 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine. The compound features a phenethylamine core with a 4-iodo-2,5-dimethoxy substitution pattern on the phenyl ring, similar to other compounds in the 25I series. The N-benzyl group is substituted with a fluorine atom, distinguishing it from other analogs such as 25I-NBOMe, which has a methoxy group instead.
Pharmacology
25I-NBF acts primarily as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor family. Activation of this receptor is associated with the psychedelic effects experienced by users. The compound may also interact with other serotonin receptor subtypes, but its affinity and activity at these sites are less well characterized.
Effects
The effects of 25I-NBF are similar to those of other psychedelic phenethylamines, including altered perception, visual hallucinations, and changes in thought processes. The intensity and duration of these effects can vary depending on the dose and individual sensitivity. As with other psychedelics, the experience can be influenced by the user's set and setting.
Safety and Toxicity
The safety profile of 25I-NBF is not well established, as it is a relatively new compound with limited research. However, compounds in the 25I series have been associated with adverse effects, including vasoconstriction, tachycardia, and hypertension. There have been reports of severe toxicity and fatalities associated with the use of related compounds, highlighting the potential risks of using 25I-NBF.
Legal Status
The legal status of 25I-NBF varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated compounds. Users should be aware of the legal implications of possessing or distributing 25I-NBF in their region.
Related Compounds
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD